EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evidence of immunogenic cell death (ICD) and ICD-dependent dendritic cell activation induced by extracorporeal photopheresis in patients with leukaemic forms of cutaneous T-cell lymphoma

Angelika Lackner, Teresa Burner iD, Marlene Huber, Saptaswa Dey iD, Stefan Aigner, Veronika Buxhofer-Ausch iD, Marija Geroldinger-Simic iD, Christoph Iselin iD, Yun-Tsan Chang iD, Yi-Chien Tsai iD, Sabine Altrichter iD, Peter Wolf iD und 3 weitere

British Journal of Dermatology · 2025

DOI: 10.1093/bjd/ljaf102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2025. Verfasst von Angelika Lackner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Center for Medical Research, Johannes Kepler University Linz, Linz, Austria. Hauptthemen laut MEDLINE: Photopheresis, Dendritic Cells, Lymphoma, T-Cell, Cutaneous, Skin Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEDImpetus, Johannes Kepler University Linz, Austrian Science Fund FWF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite novel therapeutic options, the long-term management of cutaneous T-cell lymphoma (CTCL) remains challenging. Extracorporeal photopheresis (ECP) is an immunomodulating photochemotherapy associated with higher overall survival when used for the treatment of leukaemic forms of CTCL. Its exact mode of action has not been fully elucidated. Immunogenic cell death (ICD) is pivotal in cancer immunotherapy, marked by the release of damage-associated molecular patterns that enhance dendritic cell (DC) maturation and cytotoxic T-lymphocyte responses.

Objectives

To explore ICD in patients with leukaemic forms of CTCL during ECP and its effect on DC activation.

Methods

We conducted in vitro studies with peripheral blood mononuclear cells (PBMCs) from healthy donors and ex vivo experiments with white blood cells (WBCs) from patients with leukaemic forms of CTCL undergoing ECP. We assessed cell viability, apoptosis and ICD markers [ATP, high mobility group box 1 protein (HMGB1), calreticulin] using flow cytometry, enzyme-linked immunosorbent assay and quantitative polymerase chain reaction. Engulfment assays evaluated DC activation by ECP-treated CD4+ T cells.

Results

ECP-treated healthy PBMCs and WBCs from patients with leukaemic forms of CTCL showed a significant induction of ICD hallmarks, including ATP release, HMGB1 secretion and calreticulin surface exposure. In patients with leukaemic forms of CTCL, calreticulin exposure was mainly present in CD4+CD26– T cells, indicating greater ICD susceptibility of malignant T cells. ECP-treated CD4+ T cells were phagocytosed by DCs, a process that was found to be dependent on ICD signals.

Conclusions

ECP induces ICD in malignant T cells and, to a lesser extent, in healthy T cells, facilitates DC activation. These findings suggest that ECP enhances targeted immune responses against malignant T cells in leukaemic forms of CTCL, offering new insights into its therapeutic mechanisms and potential applications in cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotopheresisDendritic CellsLymphoma, T-Cell, CutaneousSkin NeoplasmsImmunogenic Cell DeathHumansHMGB1 ProteinMiddle AgedApoptosisMaleFemaleCalreticulinLeukocytes, MononuclearAgedCell SurvivalAdenosine TriphosphateAdult

Substanzen

HMGB1 ProteinCalreticulinAdenosine TriphosphateHMGB1 protein, human

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Center for Medical Research, Johannes Kepler University Linz, Linz, Austria.
  • Department of Dermatology and Venereology and Center for Medical Research, Medical University Graz, Graz, Austria.
  • Department of Internal Medicine I with Hematology, Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz Elisabethinen, Linz, Austria.
  • Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
  • Department of Dermatology and Venereology, Ordensklinikum Linz Elisabethinen, Linz, Austria.
  • Department of Dermatology, University of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

ORCID-Profile: Teresa Burner, Saptaswa Dey, Veronika Buxhofer-Ausch, Marija Geroldinger-Simic, Christoph Iselin, Yun-Tsan Chang, Yi-Chien Tsai, Sabine Altrichter, Peter Wolf, Susanne Kimeswenger, Emmanuella Guenova, Wolfram Hoetzenecker

Förderung

  • MEDImpetus
  • Johannes Kepler University Linz
  • Austrian Science Fund FWF

Zitieren

APA

Lackner, A., Burner, T., Huber, M., Dey, S., Aigner, S., Buxhofer-Ausch, V., Geroldinger-Simic, M., Iselin, C., Chang, Y. T., Tsai, Y. C., Altrichter, S., Wolf, P., Kimeswenger, S., Guenova, E., & Hoetzenecker, W. (2025). Evidence of immunogenic cell death (ICD) and ICD-dependent dendritic cell activation induced by extracorporeal photopheresis in patients with leukaemic forms of cutaneous T-cell lymphoma. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljaf102

Vancouver

Lackner A, Burner T, Huber M, Dey S, Aigner S, Buxhofer-Ausch V, et al. Evidence of immunogenic cell death (ICD) and ICD-dependent dendritic cell activation induced by extracorporeal photopheresis in patients with leukaemic forms of cutaneous T-cell lymphoma. British Journal of Dermatology. 2025. doi:10.1093/bjd/ljaf102

BibTeX
@article{Lackner2025,
  author = {Lackner, Angelika and Burner, Teresa and Huber, Marlene and Dey, Saptaswa and Aigner, Stefan and Buxhofer-Ausch, Veronika and Geroldinger-Simic, Marija and Iselin, Christoph and Chang, Yun-Tsan and Tsai, Yi-Chien and Altrichter, Sabine and Wolf, Peter and Kimeswenger, Susanne and Guenova, Emmanuella and Hoetzenecker, Wolfram},
  title = {Evidence of immunogenic cell death (ICD) and ICD-dependent dendritic cell activation induced by extracorporeal photopheresis in patients with leukaemic forms of cutaneous T-cell lymphoma},
  journal = {British Journal of Dermatology},
  year = {2025},
  doi = {10.1093/bjd/ljaf102}
}
Kostenlos starten →